Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Cashed up MSD goes shopping

Posted 3 May 2021 AM

Watch this space for an upcoming acquisition by MSD, after the pharma's global executive team gave more than a hint that the company is cashed up and shopping for a new investment.

Speaking to investors, CEO-in-waiting Rob Davis, made no secret that the company is ready to expand, with the Mergers and Acquisitions department prepping for a new deal.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended